Reshaping cancer diagnosis and care pathways in the UK

A new generation of highly predictive biomarkers are being developed and launched to revolutionise the diagnosis and prognosis of cancer. Candesic’s Dr Chris Cassar and Marc Kitten examine the potential impact this will have on different elements of the health service and how they can prepare for the coming changes The use of biomarkers to predict…

You must be a HM Subscriber to view this content.

Subscribe Now »